Neuroendocrine cancer, a rare disease affecting hormone-making cells, tragically claimed the life of actor Irrfan Khan in ...
Neuroendocrine tumors (NETs) are a type of cancerous growth affecting cells that send hormones around the body. Pancreatic neuroendocrine tumors (PNETs) grow in the cells of the pancreas that produce ...
Peripheral primitive neuroectodermal tumors (pPNETs) are small embryonic carcinomas that develop in the soft tissue and bone, away from the central nervous system (CNS) and sympathetic nervous system ...
Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo. The Food and Drug Administration (FDA) has approved Cabometyx ® (cabozantinib) for ...
A new risk score may identify patients with node-negative pancreatic neuroendocrine tumors who face a high risk for ...
Before Exelexis’ Cabometyx can pass muster with the FDA in its hopeful neuroendocrine tumors indication next April, it will have to first face the agency’s Oncologic Drugs Advisory Committee (ODAC) in ...
Pharmacokinetic, Metabolic, and Pharmacodynamic Profiles in a Dose-Escalating Study of Irinotecan and Cisplatin ABSTRACT: Ewing’s sarcoma (ES) and primitive neuroectodermal tumor (PNET) are members of ...
News-Medical.Net on MSN
New tool can predict cancer recurrence risk in patients with pancreatic neuroendocrine tumors
Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients ...
There are known health outcome disparities among those with pancreatic neuroendocrine tumors (pNET) of minority race and those living with adverse social determinants of health (SDOH) (rurality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results